AzTrials
AzTrials

Edentulous Alveolar RidgeNCT06157047

Evaluation of the Crestal Bone Expansion Obtained With the Magnetic Mallet® During the Preparation of the Implant Site

A study testing Crestal Bone Expansion obtained with the Magnetic Mallet® in people with Edentulous Alveolar Ridge, run by Paolo Pesce at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study is to evaluate the use of a magnetodynamic instrument (Magnetic Mallet®, Metaergonomica, Turbigo, Italy) to perform a horizontal bone expansion in edentulous sites that need to be rehabilitated with a dental implant. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Edentulous Alveolar Ridge
What is being tested?
Crestal Bone Expansion obtained with the Magnetic Mallet®
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
15 participants
Where
1 siteItaly
Study dates
1 Oct 2019to 15 Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Patients with maxillary mono-edentulism between the lateral incisor and the first upper molar with a bone crest measuring between 4-6 mm;
  • Insertion of conical implants with dimensions 3.80 x > 10 mm;
  • Correct occlusal relationships between upper and lower jaw;
  • Patients willing to cooperate and follow the instructions given by the clinicians.

Who cannot join

  • Smokers > 15 cigarettes per day;
  • Patients with systemic diseases;
  • Irradiation to the head/neck region within 12 months prior to surgery;
  • Pregnancy or breastfeeding;
  • Poor oral hygiene and lack of motivation to return for checkups;
  • Edentulous area for less than 1 year;
  • Edentulousness of the lower jaw.

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • PAD 4 ospedale san martino

    Genova, 16132

Other trials in Italy

About this study

The purpose of the study is to evaluate the use of a magnetodynamic instrument (Magnetic Mallet®, Metaergonomica, Turbigo, Italy) to perform a horizontal bone expansion in edentulous sites that need to be rehabilitated with a dental implant.

Read the detailed description

From October 2019 to May 2022, a sample of 15 patients, 11 men and 4 women, age between 39 and 78 years, was analyzed. A total of 18 conical-shaped implants with a diameter of 3.80 mm and a length between 10 and 11.5 mm were inserted in the maxillary region in the area between the lateral incisor and the first upper molar. The patients were treated by two different surgeons.

Being tested
Crestal Bone Expansion obtained with the Magnetic Mallet®

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Crestal Bone Expansion obtained with the Magnetic Mallet®Procedure or surgery

    A magnetodynamic instrument (Magnetic Mallet®, Metaergonomica, Turbigo, Italy) has been used to perform a horizontal bone expansion in edentulous sites that need to be rehabilitated with a dental implant.

Study groups in NCT06157047
Study groupRoleWhat they receive
Patients includedExperimentalPatients' recruitment was guided by their actual need to solve edentulism through the use of implant therapy. The diagnosis was made clinically and radiographically.
Receives: Procedure: Crestal Bone Expansion obtained with the Magnetic Mallet®

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. bone thickness at T0

    Thickness of the bone before the surgery measured with cbct and a parodontal probe

    Measured: Before the surgery

  2. bone thickness at T1

    Thickness of the bone after the use of Magnetic Mallet measured with a parodontal probe

    Measured: Immediately after the implant site preparation

  3. bone thickness at T2

    Thickness of the bone after implant insertion measured with a parodontal probe

    Measured: Immediately after the implant insertion

Secondary outcomes (1)
  1. bone thickness at T3

    Thickness of the bone after 3 months from implant insertion measured with a cbct

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Dec 2023
  2. Study start1 Oct 2019
  3. Primary completion31 May 2022
  4. Study completion15 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
15 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06157047
Sponsor's protocol ID
Mallet
Status last verified
Dec 2023
First submitted
13 Nov 2023
Last updated
5 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Crestal Bone Expansion obtained with the Magnetic Mallet® in people with Edentulous Alveolar Ridge, run by Paolo Pesce at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

bone thickness at T0 (time frame: Before the surgery). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in